Delay in treatment with prothrombin complex concentrate (PCC)
Through its core work to review recorded patient safety events, the National Patient Safety Team identified an issue of delayed treatment for potentially life-threatening bleeds because of the time taken to authorise and obtain prothrombin complex concentrate products (PCCs). PCC are human blood products recommended for use as first line treatment for major bleeding and reversal […]